ReviewEnvironment & health (Washington, D.C.)2026
The Human Microbiome in Airborne Particulate Matter-Associated Aging-Related Chronic Diseases: An Evidence-Stratified Review.
Review in Environment & health (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Airborne particulate matter (PM) exposure is increasingly recognized for its profound impact on human health. Emerging evidence highlights the human microbiome as a plausible intermediary between environmental exposures and host physiological responses. While current research largely focuses on PM's direct toxicological effects, the role of microbiome disruption in mediating aging-related chronic diseases remains underexplored. This review integrates epidemiological data, animal models, and multiomics approaches to examine the impact of PM exposure on microbial communities across the respiratory, gut, and skin microbiomes, with a particular focus on the gut microbiome's role in aging phenotypes. We propose an evidence-stratified PM Exposure-Microbiome-Aging framework, in which the microbiome is considered a plausible exposure-sensitive interface linking environmental exposure to health outcomes, with the gut microbiota representing the most mechanistically developed interface in the current literature. By synthesizing current evidence on microbiome-linked pathways relevant to PM-associated chronic disease risk, this review provides a structured framework to guide future mechanistic and translational research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.